Using Tumor Markers to Detect Metastases in Breast Cancer
Author Information
Author(s): Nicolini A, Carpi A, Ferrari P, Anselmi L, Spinelli C, Conte M, Miccoli P
Primary Institution: University of Pisa, Pisa, Italy
Hypothesis
Can a serum tumor marker panel improve the detection of thoracic and liver metastases in breast cancer patients with equivocal imaging results?
Conclusion
The study found that the tumor marker panel effectively identifies breast cancer patients at high risk for developing metastases when imaging results are unclear.
Supporting Evidence
- The study included 467 breast cancer patients followed up postoperatively.
- Among the metastatic patients, 36 showed thoracic or liver metastases.
- The tumor marker panel had a 100% positive predictive value for predicting thoracic metastases.
- The tumor marker panel had a 100% positive predictive value for predicting liver metastases.
Takeaway
Doctors can use special blood tests to help find out if breast cancer has spread to the lungs or liver when X-rays or scans are not clear.
Methodology
This retrospective study followed 467 breast cancer patients postoperatively, assessing the effectiveness of a tumor marker panel alongside imaging techniques.
Participant Demographics
Patients included 341 non-relapsed and 126 metastatic breast cancer patients.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website